Claire C Bristow1, Sheldon R Morris2, Susan J Little2, Sanjay R Mehta2, Jeffrey D Klausner3. 1. Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA; and Corresponding author. Email: cbristow@ucsd.edu. 2. Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA. 3. Division of Infectious Diseases, Department of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA; and Department of Epidemiology, Fielding School of Public Health, University of California Los Angeles, Los Angeles, CA 90095, USA.
Abstract
Background Most studies evaluating extragenital testing performance for Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) detection by the Xpert® CT/NG show high per cent agreement with comparison assays; however, the precision around positive per cent agreement is low and thus the values that have been reported are not highly informative. Therefore, a systematic review was conducted and data from five studies were combined to better assess positive per cent agreement. METHODS: The literature indexed on PubMed.gov was searched. Included studies were those that were an evaluation of the Xpert CT/NG assay with rectal and/or pharyngeal specimen types compared with another nucleic acid amplification test (NAAT), the Aptima transcription mediated amplification assay. A full Bayesian method was used for bivariate fixed-effect meta-analysis of positive and negative per cent agreement and pooled estimates (and 95% confidence intervals (CI)) were presented for each. RESULTS: The pooled positive and negative per cent agreement for detection of CT in rectal specimens was 89.72% (95% CI: 84.97%, 93.64%) and 99.23% (95% CI: 98.74%, 99.60%), and in pharyngeal specimens, they were 89.96% (95% CI: 66.38%, 99.72%) and 99.62% (95% CI: 98.95%, 99.95%) respectively. For NG detection in rectal specimens, the pooled positive and negative per cent agreement was 92.75% (95% CI: 87.91%, 96.46%) and 99.75% (95% CI: 99.46%, 99.93%), and in pharyngeal specimens, they were 92.51% (95% CI: 85.84%, 97.18%) and 98.56% (95% CI: 97.69%, 99.23%) respectively. CONCLUSIONS: It was found that the Xpert CT/NG assay performed similarly to the Aptima transcription mediated amplification assay for the detection of CT and NG in extragenital specimens. The Xpert assay has the benefit of providing faster results at the point-of-care, thus reducing the turnaround time for results, potentially enabling same-day treatment.
Background Most studies evaluating extragenital testing performance for Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) detection by the Xpert® CT/NG show high per cent agreement with comparison assays; however, the precision around positive per cent agreement is low and thus the values that have been reported are not highly informative. Therefore, a systematic review was conducted and data from five studies were combined to better assess positive per cent agreement. METHODS: The literature indexed on PubMed.gov was searched. Included studies were those that were an evaluation of the Xpert CT/NG assay with rectal and/or pharyngeal specimen types compared with another nucleic acid amplification test (NAAT), the Aptima transcription mediated amplification assay. A full Bayesian method was used for bivariate fixed-effect meta-analysis of positive and negative per cent agreement and pooled estimates (and 95% confidence intervals (CI)) were presented for each. RESULTS: The pooled positive and negative per cent agreement for detection of CT in rectal specimens was 89.72% (95% CI: 84.97%, 93.64%) and 99.23% (95% CI: 98.74%, 99.60%), and in pharyngeal specimens, they were 89.96% (95% CI: 66.38%, 99.72%) and 99.62% (95% CI: 98.95%, 99.95%) respectively. For NG detection in rectal specimens, the pooled positive and negative per cent agreement was 92.75% (95% CI: 87.91%, 96.46%) and 99.75% (95% CI: 99.46%, 99.93%), and in pharyngeal specimens, they were 92.51% (95% CI: 85.84%, 97.18%) and 98.56% (95% CI: 97.69%, 99.23%) respectively. CONCLUSIONS: It was found that the Xpert CT/NG assay performed similarly to the Aptima transcription mediated amplification assay for the detection of CT and NG in extragenital specimens. The Xpert assay has the benefit of providing faster results at the point-of-care, thus reducing the turnaround time for results, potentially enabling same-day treatment.
Authors: Laura Dize; Sheila West; James A Williams; Barbara Van Der Pol; Thomas C Quinn; Charlotte A Gaydos Journal: J Clin Microbiol Date: 2013-03-13 Impact factor: 5.948
Authors: Jennifer Gratrix; Ameeta E Singh; Joshua Bergman; Caroline Egan; Sabrina S Plitt; Justin McGinnis; Christopher A Bell; Steven J Drews; Ron Read Journal: Clin Infect Dis Date: 2014-10-21 Impact factor: 9.079
Authors: B Van Der Pol; T C Quinn; C A Gaydos; K Crotchfelt; J Schachter; J Moncada; D Jungkind; D H Martin; B Turner; C Peyton; R B Jones Journal: J Clin Microbiol Date: 2000-03 Impact factor: 5.948
Authors: Charlotte A Gaydos; Mellisa Theodore; Nicholas Dalesio; Billie Jo Wood; Thomas C Quinn Journal: J Clin Microbiol Date: 2004-07 Impact factor: 5.948
Authors: C A Gaydos; T C Quinn; D Willis; A Weissfeld; E W Hook; D H Martin; D V Ferrero; J Schachter Journal: J Clin Microbiol Date: 2003-01 Impact factor: 5.948
Authors: Lisa A Cosentino; Claire S Danby; Lorna K Rabe; Ingrid Macio; Leslie A Meyn; Harold C Wiesenfeld; Sharon L Hillier Journal: J Clin Microbiol Date: 2017-07-05 Impact factor: 5.948
Authors: Claire S Danby; Lisa A Cosentino; Lorna K Rabe; Carol L Priest; Khrystine C Damare; Ingrid S Macio; Leslie A Meyn; Harold C Wiesenfeld; Sharon L Hillier Journal: Sex Transm Dis Date: 2016-02 Impact factor: 2.830
Authors: Gary G Whitlock; Daniel C Gibbons; Nick Longford; Michael J Harvey; Alan McOwan; Elisabeth J Adams Journal: Int J STD AIDS Date: 2017-10-23 Impact factor: 1.359